
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B - TechCrunch
Miles Wang's new startup is focused on developing AI models for drug discovery. The company aims to leverage AI to find new uses for existing drugs and potentially those that previously failed in trials, which can lead to faster revenue generation compared to developing new drugs from scratch.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B TechCrunch

| Jul 21, 2026 | Plazza | $15.0M | — | — |
| Jul 20, 2026 | Betterhood | $60K | Seed | India |
| Jul 15, 2026 | Ultrahuman | $60.0M | — | India |
| Jul 15, 2026 | IM8 | $1.00B | Debt | United States |